Michelle Stanton is trying to reduce malaria deaths by better understanding where mosquito breeding spots are. She’s using the power of drones to capture aerial imagery in Malawi’s drone corridor – a patch of land devoted to humanitarian drone testing.
Dr Deborah O’Neil is the CEO of Novabiotics, a leading clinical-stage biotechnology company. She talks to me about antibiotic resistance and the future of pharma with so-called ‘personalised medicines’.
There’s a significant shortage of people working in STEM, costing businesses £1.5 billion a year. Katherine Andrews, the Project Manager of ‘That’s RAD! Science’ is trying to change that by bringing STEM careers to life through educational picture books.
Joining me today is Rob Mather, the CEO of the Against Malaria Foundation. The foundation funds anti-malaria nets, specifically long-lasting insecticidal nets, LLINs.
Access to healthcare can be extremely limited, with the nearest health facility located hours away. Transaid is using bicycle ambulances to transport mothers and children.
What makes a public health animation effective and, as the NHS introduces an online quiz to determine heart age, will such quizzes have a greater role in public health?
Margaret Reilly McDonnell, the Executive Director of Nothing But Nets discusses the importance of mosquito nets, the growing issue of insecticide resistance and cuts to foreign aid.
Dr Mike Coleman and Kirsten Duda of the Liverpool School of Tropical Medicine discuss their mobile game, Resistance 101, that aims to make concepts of insecticide resistance more accessible and engaging.
Live from Durham University, I speak with Professor Steve Lindsay. His research in developing a new type of mosquito net has hit the headlines, being described as ‘revolutionary’, with the potential to save hundreds of thousands of lives.
We’re joined by Professor Archie Clements who is Pro Vice-Chancellor of Health Sciences at Curtin University, Australia. He shares his views on the Malaria World Congress that took place in Melbourne earlier this year, and on the FDA’s approval of Tafenoquine.